1. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion
- Author
-
Philip J. O'Connell, Brian J. Nankivell, Jeremy R. Chapman, Caroline L.-S. Fung, Richard Borrows, Karen L. Keung, and Meena Shingde
- Subjects
Adult ,Graft Rejection ,Male ,medicine.medical_specialty ,T-Lymphocytes ,medicine.medical_treatment ,030232 urology & nephrology ,Renal function ,030230 surgery ,Kidney Function Tests ,Gastroenterology ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Isoantibodies ,Risk Factors ,Glomerulopathy ,Fibrosis ,Internal medicine ,Biopsy ,medicine ,Humans ,Immunology and Allergy ,Pharmacology (medical) ,Longitudinal Studies ,Prospective Studies ,Kidney transplantation ,Inflammation ,Transplantation ,medicine.diagnostic_test ,business.industry ,Graft Survival ,Immunosuppression ,Hyperplasia ,Prognosis ,medicine.disease ,Kidney Transplantation ,Tacrolimus ,Kidney Tubules ,Histocompatibility ,Female ,Kidney Diseases ,business ,Follow-Up Studies ,Glomerular Filtration Rate - Abstract
Inflammation within areas of interstitial fibrosis and tubular atrophy (i-IFTA) is associated with adverse outcomes in kidney transplantation. We evaluated i-IFTA in 429 indication- and 2052 protocol-driven biopsy samples from a longitudinal cohort of 362 kidney-pancreas recipients to determine its prevalence, time course, and relationships with T cell-mediated rejection (TCMR), immunosuppression, and outcome. Sequential histology demonstrated that i-IFTA was preceded by cellular interstitial inflammation and followed by IF/TA. The prevalence and intensity of i-IFTA increased with developing chronic fibrosis and correlated with inflammation, tubulitis, and immunosuppression era (P
- Published
- 2018
- Full Text
- View/download PDF